TTrialPathMatch Me to Trials
← Back to trials
RecruitingChronic Respiratory ConditionsObstructive Sleep Apnea (OSA)

Evaluation of the F&P Mask, US, 2026

Eligible age

22+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This clinical investigation is designed to validate and confirm the overall performance, safety, usability, reliability, and acceptability of the F\&P PAP mask in a home environment.

Sponsor: Fisher and Paykel Healthcare

You may qualify if…

  • ✓ Are ≥22 years of age
  • ✓ Weigh ≥66 pounds
  • ✓ Have been prescribed PAP/NIV therapy by a physician
  • ✓ Are an existing PAP/NIV therapy mask user with ≥3 months of use prior to enrolment in the clinical investigation\*
  • ✓ Are compliant with PAP/NIV therapy for ≥4 hours per night for ≥70% of nights for a 14-day period within 30 days prior to enrolment in the clinical investigation
  • ✓ Are fluent in spoken and written English
  • ✓ Possess the capacity to provide informed consent

You may not qualify if…

  • ✕ Are intolerant to PAP/NIV therapy
  • ✕ Possess, or suffer from, anatomical or physiological conditions which make PAP/NIV therapy inappropriate
  • ✕ Are required to use PAP/NIV therapy for \>12 hours per day or for extensive periods, not including sleep or naps
  • ✕ Are trying to get pregnant, are pregnant, or think they may be pregnant
  • ✕ Have an IPAP pressure of \>30 cmH2O if on BPAP
  • ✕ Use a PAP/NIV therapy device for the delivery of medicines, except supplemental O2
  • ✕ Use a PAP/NIV therapy device that does not possess data recording capabilities to capture AHI and a numerical indicator of leak that is accessible to the clinical investigation site
  • ✕ Have a history of light-induced seizures (for optional anthropometric scan only)

Where it's recruiting

Missouri

St Louis

Source: ClinicalTrials.gov · NCT07826429 · last updated 2026-10-16

Evaluation of the F&P Mask, US, 2026 · TrialPath